Inventor · disambiguated record

Lei Ling

Also filed as: LING LEI

37 granted patents·20 pending applications·596 citations·filing 1998–2023

98Inventor score

Technology areasA61P A61K G01N C07K B01D

Files withNGM BIOPHARMACEUTICALS INC42 FX LIFE SCIENCES INTERNAT GMBH3 PURDUE RESEARCH FOUNDATION3 AMGEN INC2 C V TECHNOLOGIES INC2

Top patents by PatentIndex Score

57 records

0198US9751924B2Methods of using compositions comprising fusion variants of FGF19 polypeptides for reducing glucose levels in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Sep 5, 2017·32 cites·113 claims
0298US9670260B2Compositions comprising fusion variants of FGF19 polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Jun 6, 2017·34 cites·28 claims
0398US9580483B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of diabetesNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Feb 28, 2017·36 cites·120 claims
0498US9089525B1Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Jul 28, 2015·37 cites·91 claims
0597US9974833B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having pregnancy intrahepatic cholestasisNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted May 22, 2018·19 cites·54 claims
0697US9895416B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having cholestasisNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Feb 20, 2018·25 cites·54 claims
0797US9889177B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having primary sclerosing cholangitisNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Feb 13, 2018·25 cites·54 claims
0897US9889178B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having nonalcoholic steatohepatitisNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Feb 13, 2018·25 cites·54 claims
0997US9878008B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having bile acid diarrhea or bile acid malabsorptionNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Jan 30, 2018·26 cites·54 claims
1097US9878009B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having error of bile acid synthesisNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Jan 30, 2018·25 cites·54 claims
1197US9290557B2Compositions comprising variants and fusions of FGF19 polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2013·Granted Mar 22, 2016·37 cites·63 claims
1297US9273107B2Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseasesNGM BIOPHARMACEUTICALS INC·Filed 2013·Granted Mar 1, 2016·36 cites·63 claims
1396US10456449B2Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseasesNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Oct 29, 2019·10 cites·63 claims
1496US9963494B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2013·Granted May 8, 2018·19 cites·85 claims
1595US10398758B2Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditionsNGM BIOPHARMACEUTICALS INC·Filed 2015·Granted Sep 3, 2019·9 cites·32 claims
1695US8951966B2Compositions comprising variants and fusions of FGF19 polypeptides, and uses and methods thereof for treatment of metabolic disorders and diseasesLING LEI·Filed 2012·Granted Feb 10, 2015·61 cites·46 claims
1794US10413590B2Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Sep 17, 2019·10 cites·121 claims
1894US9925242B2Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of nonalcoholic steatohepatitisNGM BIOPHARMACEUTICALS INC·Filed 2013·Granted Mar 27, 2018·25 cites·52 claims
1989US10744185B2Methods of using variants of FGF19 polypeptides for the treatment of pruritusNGM BIOPHARMACEUTICALS INC·Filed 2016·Granted Aug 18, 2020·7 cites·52 claims
2089US7413756B2Processes of making north american ginseng fractions, products containing them, and use as immunomodulatorsFX LIFE SCIENCES INTERNAT GMBH·Filed 2005·Granted Aug 19, 2008·12 cites·11 claims
2188US10369199B2Methods of using variants of FGF19 polypeptides for the treatment of cancerNGM BIOPHARMACEUTICALS INC·Filed 2014·Granted Aug 6, 2019·9 cites·25 claims
2288US2024050530A1Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Metabolic Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
2385US11241481B2Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseasesNGM BIOPHARMACEUTICALS INC·Filed 2019·Granted Feb 8, 2022·1 cites·16 claims
2484US2023226151A1Methods for Modulating Bile Acid Homeostasis and Treatment of Bile Acid Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
2582US7186423B2Processes of making North American ginseng fractions, products containing them, and uses as immunomodulatorsFX LIFE SCIENCES INTERNAT GMBH·Filed 2003·Granted Mar 6, 2007·12 cites·9 claims
2678US2022088140A1Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Metabolic Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
2777US7195783B2Hypericin and hypericum extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeuticsFX LIFE SCIENCES INTERNAT GMBH·Filed 2000·Granted Mar 27, 2007·12 cites·16 claims
2877US7067160B2Processes of making North American ginseng fractions, products containing them, and use as immunomodulatorsC V TECHNOLOGIES INC·Filed 2002·Granted Jun 27, 2006·8 cites·25 claims
2976US11065302B2Compositions comprising fusion variants of FGF19 polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·0 cites·12 claims
3075US11103554B2Methods of using compositions comprising variants of FGF19 polypeptides for reducing bile acid synthesis in a subject having cirrhosisNGM BIOPHARMACEUTICALS INC·Filed 2019·Granted Aug 31, 2021·0 cites·55 claims
3175US6432454B1Processes of making north american ginseng fractions, products containing them, and use as immunomodulatorsC V TECHNOLOGIES INC·Filed 1998·Granted Aug 13, 2002·27 cites·9 claims
3274US7056685B1Receptor ligands and methods of modulating receptorsAMGEN INC·Filed 2003·Granted Jun 6, 2006·9 cites·5 claims
3372US2022241373A1Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseasesNGM BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
3471US11564972B2Methods of using compositions comprising variants of FGF19 polypeptides for treating primary biliary cirrhosis in a subjectNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Jan 31, 2023·0 cites·18 claims
3571US10597751B2Ligand assisted chromatography for metal ion separationPURDUE RESEARCH FOUNDATION·Filed 2015·Granted Mar 24, 2020·1 cites·11 claims
3670US7763290B2Processes of making north american ginseng fractions, products containing them, and use as immunomodulatorsFX LifeSciences AG·Filed 2008·Granted Jul 27, 2010·1 cites·7 claims
3768US2020308668A1Ligand Assisted Chromatography for Metal Ion SeparationPURDUE RESEARCH FOUNDATION·Filed 2019·Application pending·0 cites
3868US2019060403A1Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseasesNGM BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
3968US2021189519A1Ligand assisted chromatography for metal ion separationPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
4067US11066454B2Compositions comprising variants and fusions of FGF19 polypeptidesNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·0 cites·10 claims
4167US10758590B2Methods of using compositions comprising variants and fusions of FGF 19 polypeptides for treating diabetesNGM BIOPHARMACEUTICALS INC·Filed 2018·Granted Sep 1, 2020·0 cites·38 claims
4267US2023034473A1Methods of treating fibroblast growth factor 19-mediated cancers and tumorsNGM BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
4366US11370841B2Methods of treating fibroblast growth factor 19-mediated cancers and tumorsNGM BIOPHARMACEUTICALS INC·Filed 2017·Granted Jun 28, 2022·0 cites·11 claims
4466US2019175692A1Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Nonalcoholic Fatty Liver DiseaseNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
4566US2021169983A1Compositions and Methods for Treatment of Metabolic Disorders and DiseasesNGM BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
4666US2019175694A1Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Liver FibrosisNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
4766US2019175693A1Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of CirrhosisNGM BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
4862US6593340B1Pharmaceutical compositions containing N-propargylphentermine and related analogs to treat neurodegeneration and/or depressionCV TECHNOLOGIES INC·Filed 2001·Granted Jul 15, 2003·4 cites·16 claims
4960US8642094B2Synergistic pharmaceutical composition, method of making same and use of sameSHAN JACQUELINE J·Filed 2009·Granted Feb 4, 2014·2 cites·25 claims
5059US2016200788A1Compositions, uses and methods for treatment of metabolic disorders and diseasesNGM BIOPHARMACEUTICALS INC·Filed 2015·Application pending·0 cites

Showing the top 50 of 57 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Lei Ling files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →